Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
03/28/2000 | US6043073 Phospholipase D polypeptide and DNA sequences |
03/28/2000 | US6043071 GlmU |
03/28/2000 | US6043056 Amino acid sequences; for diagnosis, treatment, and prevention of blood, karyotypic, and nervous system disorders |
03/28/2000 | US6043054 Polynucleotides encoding a novel GABA BP polypeptide |
03/28/2000 | US6043053 Wnt-3 polynucleotides |
03/28/2000 | US6043052 Nucleotide and amino acid sequences of g protein coupled receptor; for diagnosis and treatment of related diseases; anticarcinogenic/antidiabetic/antiulcer agents; antidepressants; hypotensive/hypertensive agents |
03/28/2000 | US6043044 Macrophage migration inhibitory factor as diagnostic and prognostic marker for metastatic adenocarcinoma |
03/28/2000 | US6043043 Assaying blood sample for amount of hemoglobin, assaying for amount of hemoglobin adduct, normalizing the measurement of adduct, dividing normalized adduct concentration by total hemoglobin concentration for corrected value |
03/28/2000 | US6043042 Antibody which binds cleavage fragment of nerve cell peptide produced by action of a toxin; for immunoassays |
03/28/2000 | US6043041 Amplification and detection of Shiga-like toxin II producing organisms |
03/28/2000 | US6043040 Csak-3 nucleic acid molecules and uses therefor |
03/28/2000 | US6043039 Obtaining chromosome spread, preparing composite of chromosomal paints, denaturing composite and renaturing leaving unique sequences single-stranded, hybridizing to chromosomes, washing, analyzing and presenting images |
03/28/2000 | US6043034 Mixing sample, raman scattering active agent which binds to polynucleotide, and surface-enhanced raman scattering active substrate which bonds excess agent; irradiating; measuring radiation generated by agent captured on surface of substrate |
03/28/2000 | US6043031 DNA diagnostics based on mass spectrometry |
03/28/2000 | US6043030 Cell-cycle regulatory proteins, and uses related thereto |
03/28/2000 | US6043025 Kit containing matched set of luminescent dyes capable of covalently binding to protein; dyes migrate the same but have different emission wavelengths; for simple, fast and accurate method of comparing/contrasting protein content of samples |
03/28/2000 | US6043024 Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules |
03/28/2000 | US6042874 Fixing sample, simultaneously applying a mixture of dehydration agent and lipophilic clearing agent to sample, impregnating sample |
03/28/2000 | US6042824 Combining the substrate and a crosslinked enzyme crystal formulation containing a crosslinked enzyme and a surfactant which acts upon the substrate in presence of organic solvent or aqueous-organic solvent to form a product |
03/28/2000 | US6042788 For detecting analytes in gaseous or liquid phase in solutions, characterised in that the chemically sensitive sensors comprise a chemically sensitive probe of arylene alkenylene oligomers, alone or in a mixture |
03/28/2000 | US6042786 Apparatus for automatically analyzing sample |
03/28/2000 | US6042751 Platinum group metal powder, modified graphite, and thermoplastic resin |
03/28/2000 | US6042715 Method for modeling the crystallization of paraffins in petroleum fluids |
03/28/2000 | US6042543 Flat structure; collection of test sample of sweat sandwiched between two liquid-impermeable layers; chloride ions in sweat complex with a chloride-detecting agent to form a visible precipitate; diagnosis of cystic fibrosis |
03/28/2000 | US6041669 Methods of and apparatus for testing and venting drums |
03/28/2000 | US6041661 Method and apparatus of testing board product |
03/28/2000 | US6041660 Tensile strength tester |
03/28/2000 | US6041643 Gas sensor with protective gate, method of forming the sensor, and method of sensing |
03/28/2000 | CA2270334A1 Diagnostics based on tetrazolium compounds |
03/28/2000 | CA2265201A1 Diagnostics based on tetrazolium compounds |
03/28/2000 | CA2245903A1 Use of pex in the treatment of metabolic bone diseases |
03/28/2000 | CA2180658C Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
03/23/2000 | WO2000016231A1 Method for screening and producing compound libraries |
03/23/2000 | WO2000016103A1 Method for detecting or quantifying basophils and eosinophils |
03/23/2000 | WO2000016102A1 Control of the activity transmitted by a tyrosine kinase receptor |
03/23/2000 | WO2000016101A2 Target analyte sensors utilizing microspheres |
03/23/2000 | WO2000016100A1 Methods for identifying hot-spot residues of binding proteins and small compounds that bind to the same |
03/23/2000 | WO2000016099A1 Recombinant reduced valency carbohydrate binding ligands |
03/23/2000 | WO2000016098A1 Composite devices incorporating biological material and methods |
03/23/2000 | WO2000016096A1 Artificial olfactory sensing system |
03/23/2000 | WO2000016095A1 Method and apparatus for producing a gas having a controlled release |
03/23/2000 | WO2000016094A1 Method of detecting thiol-containing compound |
03/23/2000 | WO2000016092A2 Energetic quantification method for composite materials |
03/23/2000 | WO2000016091A1 Chemical sensor array |
03/23/2000 | WO2000016089A2 Signal detection techniques for the detection of analytes |
03/23/2000 | WO2000016082A1 Device comprising a plurality of analysis sites on a support |
03/23/2000 | WO2000016080A1 Method for producing a reference electrode for a galvanic cell with cation-conducting solid electrolytes |
03/23/2000 | WO2000016068A1 REMOTE EMISSIONS SENSING SYSTEM WITH IMPROVED NOx DETECTION |
03/23/2000 | WO2000016065A1 Histological processing of tissue and other material |
03/23/2000 | WO2000016062A2 Methods for determining the activity of complex mixtures |
03/23/2000 | WO2000016061A2 Method for diagnosing the active stage of a cytomegalovirus infection in human substrates |
03/23/2000 | WO2000015851A1 Geometrical and hierarchical classification based on gene expression |
03/23/2000 | WO2000015850A1 Assays for measuring nucleic acid binding proteins and enzyme activities |
03/23/2000 | WO2000015845A1 T-type calcium channel |
03/23/2000 | WO2000015844A1 Nucleic acid sequencing with solid phase capturable terminators |
03/23/2000 | WO2000015841A1 Method and kit for detecting intrachromosome imbalance in inter phase nuclei and their applications |
03/23/2000 | WO2000015840A1 Method for determining susceptibility to heart disease by screening polymorphisms in the vitamin d receptor gene |
03/23/2000 | WO2000015838A2 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
03/23/2000 | WO2000015826A2 Leptin induced genes |
03/23/2000 | WO2000015807A1 Method for down-regulating osteoprotegerin ligand activity |
03/23/2000 | WO2000015806A1 Atp synthase subunit homolog |
03/23/2000 | WO2000015805A1 Use of protein kinase kiaa0551 as pharmaceutical |
03/23/2000 | WO2000015802A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
03/23/2000 | WO2000015801A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
03/23/2000 | WO2000015797A2 Compositions and methods for the treatment of immune related diseases |
03/23/2000 | WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization |
03/23/2000 | WO2000015790A2 Leptin induced genes |
03/23/2000 | WO2000015788A2 Dna sequence encoding oncofetal ferritin protein |
03/23/2000 | WO2000015787A1 Genes encoding for the human and murine death inducer-obliterator-1 |
03/23/2000 | WO2000015786A1 Metabotropic gaba receptor complex issued from the central nervous system |
03/23/2000 | WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN |
03/23/2000 | WO2000015784A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
03/23/2000 | WO2000015780A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer |
03/23/2000 | WO2000015777A1 Gene and protein libraries and methods relating thereto |
03/23/2000 | WO2000015775A1 Rnase p polypeptides |
03/23/2000 | WO2000015769A1 Topa |
03/23/2000 | WO2000015666A2 Compositions and methods for the treatment of tumors |
03/23/2000 | WO2000015665A2 A method of producing a functional immunoglobulin superfamily protein |
03/23/2000 | WO2000015659A2 Stomach polypeptide zsig28 |
03/23/2000 | WO2000015650A1 Polynucleotide and polypeptide sequences encoding rat mdr1a and screening methods thereof |
03/23/2000 | WO2000015618A1 Xanthan-ester and acridan substrates for horseradish peroxidase |
03/23/2000 | WO2000015258A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis |
03/23/2000 | WO2000015242A1 REGULATION OF HER2/neu ONCOGENE EXPRESSION BY SYNTHETIC POLYAMIDES |
03/23/2000 | WO2000015209A2 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES |
03/23/2000 | WO2000015178A2 Computer implemented pharmacokinetics method and program |
03/23/2000 | WO2000015169A1 Diaper with indicators sensitive to the status of the impregnated urine and visible from outside |
03/23/2000 | WO2000015108A1 Press device for a gel/sensor assembly |
03/23/2000 | WO2000015020A1 Immunoassay that provides for both collection of saliva and assay of saliva |
03/23/2000 | WO2000008160A3 A plant disease resistance signalling gene: materials and methods relating thereto |
03/23/2000 | WO2000003244A9 Immortalized human keratinocyte cell line |
03/23/2000 | WO2000000808A3 Colloidal particles used in sensing arrays |
03/23/2000 | WO2000000646A9 METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS |
03/23/2000 | WO2000000643A3 Methods and reagents for detecting fungal pathogens in a biological sample |
03/23/2000 | WO2000000611A3 14273 receptor, a g-protein coupled receptor |
03/23/2000 | WO1999067359A3 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
03/23/2000 | WO1999066024A9 Methods of monitoring disease states and therapies using gene expression profiles |
03/23/2000 | WO1999064864A9 Optimizing sensitivity in colloidal colorimetric flow through and lateral flow tests |
03/23/2000 | WO1999064057A9 Retinoic acid inducible dna sequences from lung cells |
03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
03/23/2000 | WO1999061909A3 Methods and compositions for the detection of human herpesvirus |